Postmenopausal Vaginal Atrophy - Epidemiology Insights to 2025

Publisher Name :
Date: 28-Jul-2017
No. of pages: 40
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's "Postmenopausal Vaginal Atrophy -Epidemiology Forecast, 2025" provides an overview of the epidemiology trends of Postmenopausal Vaginal Atrophy in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Postmenopausal Vaginal Atrophy. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical needs associated with the Postmenopausal Vaginal Atrophy. The report contains the targeted patient populations and the forecast methodology.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by DelveInsight team of industry experts.

Key Coverage and Benefits

  • The Report includes the prevalent population and how will it change over the next eight years.

  • Coverage of key Postmenopausal Vaginal Atrophy sub-populations and its prevalent or incident cases

  • Prevalent or incident cases segmented by age and sex.

  • The key differences in epidemiology patterns across the seven market segments.

Reasons to buy

  • Developing business strategies by understanding the trends shaping and driving the global Postmenopausal Vaginal Atrophy market.

  • Identifying prevalent patient populations as well as risk factors in the global Postmenopausal Vaginal Atrophy market will help to improve product design, pricing, and launch plans.

  • Organize sales and marketing efforts by identifying the best opportunities for Postmenopausal Vaginal Atrophy therapeutics in each of the markets covered.

Postmenopausal Vaginal Atrophy - Epidemiology Insights to 2025

Table of Contents

1. Report Introduction

2. Snapshot of Total Prevalent or Incident cases by 7 MM

3. Executive Summary
Key Findings

4. Postmenopausal Vaginal Atrophy Overview
Postmenopausal Vaginal Atrophy Definition
Pathophysiology
Symptoms
Etiology

5. Risk Factors Associated with Postmenopausal Vaginal Atrophy

6. Disease Burden & Unmet Need in the Market

7. Epidemiology and Patient Populations
Key Findings
Key Sources used and Forecast Methodology
Prevalent Cases and Incident Cases-2015-2025
Prevalent & Incident Cases by Category-2015-2025
Age-Specific Prevalent/ Incident Cases of Postmenopausal Vaginal Atrophy
Sex-Specific Prevalent/Incident Cases of Postmenopausal Vaginal Atrophy
Disease Type Specific Prevalent/Incident Cases of Postmenopausal Vaginal Atrophy

8.Prevalent & Incident Cases by 7 MM-2015-2025
Postmenopausal Vaginal Atrophy Epidemiology of United States-2025
Postmenopausal Vaginal Atrophy Epidemiology of United Kingdom-2025
Postmenopausal Vaginal Atrophy Epidemiology of Germany-2025
Postmenopausal Vaginal Atrophy Epidemiology of France-2025
Postmenopausal Vaginal Atrophy Epidemiology of Spain-2025
Postmenopausal Vaginal Atrophy Epidemiology of Italy-2025
Postmenopausal Vaginal Atrophy Epidemiology of Japan-2025

9. Key Takeaways

10. Appendix

11.Report Methodology

12. Consulting Services

13. Disclaimer

14. About Us

List of Tables

Table 1: Clinical subtypes of Indication
Table 2: Risk Factors
Table 3: Prevalence cases (%) Region wise
Table 4: Sources used for forecasting the data
Table 5: Postmenopausal Vaginal Atrophy Global Epidemiology, (2015-2025)
Table 6: Prevalent Cases of Postmenopausal Vaginal Atrophy (Ages =XX Years), US (2015-2025)
Table 7: Prevalent Cases of Postmenopausal Vaginal Atrophy By Sex (Males & Females), US (2015-2025)
Table 8: Prevalent Cases By Postmenopausal Vaginal Atrophy Sub-population, US (2015-2025)
Table 9: Prevalent Cases of Postmenopausal Vaginal Atrophy (Ages =XX Years), United Kingdom (2015-2025)
Table 10: Prevalent Cases of Postmenopausal Vaginal Atrophy By Sex (Males & Females), United Kingdom (2015-2025)
Table 11: Prevalent Cases By Postmenopausal Vaginal Atrophy Sub-population, United Kingdom (2015-2025)
Table 12: Prevalent Cases of Postmenopausal Vaginal Atrophy (Ages =XX Years), Germany (2015-2025)
Table 13: Prevalent Cases of Postmenopausal Vaginal Atrophy By Sex (Males & Females), Germany (2015-2025)
Table 14: Prevalent Cases By Postmenopausal Vaginal Atrophy Sub-population, Germany (2015-2025)
Table 15: Prevalent Cases of Postmenopausal Vaginal Atrophy (Ages =XX Years), France (2015-2025)
Table 16: Prevalent Cases of Postmenopausal Vaginal Atrophy By Sex (Males & Females), France (2015-2025)
Table 17: Prevalent Cases By Postmenopausal Vaginal Atrophy Sub-population, France (2015-2025)
Table 18: Prevalent Cases of Postmenopausal Vaginal Atrophy (Ages =XX Years), Italy (2015-2025)
Table 19: Prevalent Cases of Postmenopausal Vaginal Atrophy By Sex (Males & Females), Italy (2015-2025)
Table 20: Prevalent Cases By Postmenopausal Vaginal Atrophy Sub-population, Italy (2015-2025)
Table 21: Prevalent Cases of Postmenopausal Vaginal Atrophy (Ages =XX Years), Spain (2015-2025)
Table 22: Prevalent Cases of Postmenopausal Vaginal Atrophy By Sex (Males & Females), Spain (2015-2025)
Table 23: Prevalent Cases By Postmenopausal Vaginal Atrophy Sub-population, Spain (2015-2025)
Table 24: Prevalent Cases of Postmenopausal Vaginal Atrophy (Ages =XX Years), Japan (2015-2025)
Table 25: Prevalent Cases of Postmenopausal Vaginal Atrophy By Sex (Males & Females), Japan (2015-2025)
Table 26: Prevalent Cases By Postmenopausal Vaginal Atrophy Sub-population, Japan (2015-2025)

List of Figures

Figure 1: Prevalence cases (%) Region wise
Figure 2: Sources used for forecasting the data
Figure 3: Postmenopausal Vaginal Atrophy Global Epidemiology, (2015-2025)
Figure 4: Prevalent Cases of Postmenopausal Vaginal Atrophy (Ages =XX Years), US (2015-2025)
Figure 5: Prevalent Cases of Postmenopausal Vaginal Atrophy By Sex (Males & Females), US (2015-2025)
Figure 6: Prevalent Cases By Postmenopausal Vaginal Atrophy Sub-population,US (2015-2025)
Figure 7: Prevalent Cases of Postmenopausal Vaginal Atrophy (Ages =XX Years), United Kingdom (2015-2025)
Figure 8: Prevalent Cases of Postmenopausal Vaginal Atrophy By Sex (Males & Females), United Kingdom (2015-2025)
Figure 9: Prevalent Cases By Postmenopausal Vaginal Atrophy Sub-population,United Kingdom (2015-2025)
Figure 10: Prevalent Cases of Postmenopausal Vaginal Atrophy (Ages =XX Years), Germany (2015-2025)
Figure 11: Prevalent Cases of Postmenopausal Vaginal Atrophy By Sex (Males & Females), Germany (2015-2025)
Figure 12: Prevalent Cases By Postmenopausal Vaginal Atrophy Sub-population,Germany (2015-2025)
Figure 13: Prevalent Cases of Postmenopausal Vaginal Atrophy (Ages =XX Years), France (2015-2025)
Figure 14: Prevalent Cases of Postmenopausal Vaginal Atrophy By Sex (Males & Females), France (2015-2025)
Figure 15: Prevalent Cases By Postmenopausal Vaginal Atrophy Sub-population,France (2015-2025)
Figure 16: Prevalent Cases of Postmenopausal Vaginal Atrophy (Ages =XX Years), Italy (2015-2025)
Figure 17: Prevalent Cases of Postmenopausal Vaginal Atrophy By Sex (Males & Females), Italy (2015-2025)
Figure 18: Prevalent Cases By Postmenopausal Vaginal Atrophy Sub-population,Italy (2015-2025)
Figure 19: Prevalent Cases of Postmenopausal Vaginal Atrophy (Ages =XX Years), Spain (2015-2025)
Figure 20: Prevalent Cases of Postmenopausal Vaginal Atrophy By Sex (Males & Females), Spain (2015-2025)
Figure 21: Prevalent Cases By Postmenopausal Vaginal Atrophy Sub-population,Spain (2015-2025)
Figure 22: Prevalent Cases of Postmenopausal Vaginal Atrophy (Ages =XX Years), Japan (2015-2025)
Figure 23: Prevalent Cases of Postmenopausal Vaginal Atrophy By Sex (Males & Females), Japan (2015-2025)
Figure 24: Prevalent Cases By Postmenopausal Vaginal Atrophy Sub-population,Japan (2015-2025)
  • Global Contraceptives Market Research Report 2017
    Published: 19-Oct-2017        Price: US 2900 Onwards        Pages: 113
    In this report, the global Contraceptives market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Contraceptives in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - Japan......
  • Global Topical Contraceptive Market Research Report 2017
    Published: 17-Oct-2017        Price: US 2900 Onwards        Pages: 121
    In this report, the global Topical Contraceptive market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Topical Contraceptive in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China......
  • Female Hypoactive Sexual Desire Disorder - Pipeline Review, H2 2017
    Published: 10-Oct-2017        Price: US 2000 Onwards        Pages: 46
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Female Hypoactive Sexual Desire Disorder - Pipeline Review, H2 2017, provides an overview of the Female Hypoactive Sexual Desire Disorder (Women's Health) pipeline landscape.Hypoactive sexual desire disorder (HSDD) is an absence of sexual fantasies and desire for sexual activity. The predisposing factors include anxiety, depression, androgen deficiencies, and chronic debilitating illnesses, such as chronic ren......
  • Premenstrual Syndrome - Pipeline Review, H2 2017
    Published: 10-Oct-2017        Price: US 2000 Onwards        Pages: 28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Premenstrual Syndrome - Pipeline Review, H2 2017, provides an overview of the Premenstrual Syndrome (Women's Health) pipeline landscape.Premenstrual syndrome (PMS) is a collection of physical and emotional symptoms related to a woman's menstrual cycle. Premenstrual syndrome has a wide variety of symptoms, including mood swings, tender breasts, food cravings, fatigue, irritability and depression.Repo......
  • Women Infertility - Pipeline Review, H2 2017
    Published: 10-Oct-2017        Price: US 2000 Onwards        Pages: 187
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Women Infertility - Pipeline Review, H2 2017, provides an overview of the Women Infertility (Women's Health) pipeline landscape.Infertility refers to failure to conceive over the course of one full year. Women infertility is caused due to damage of fallopian tubes, ovulation disorders (polycystic ovary syndrome) and endometriosis. Symptoms include abnormal periods, weight gain, back pain, pelvic pain, and cram......
  • Global Bacterial Vaginosis Drug Market Professional Survey Report 2017
    Published: 09-Oct-2017        Price: US 3500 Onwards        Pages: 113
    This report studies Bacterial Vaginosis Drug in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Bayer - Pfizer - Sanofi - Piramal - Abbott - ......
  • Global Postmenopausal Vaginal Atrophy Treatment Market Research Report 2011-2023
    Published: 03-Oct-2017        Price: US 1940 Onwards        Pages: 85
    Summary Vaginal atrophy, also known as urogenital atrophy or atrophic vaginitis, is the inflammation of the vagina. It is the result of the vaginal tissues getting shrunken and thinned out. The most common cause of vaginal atrophy is the lack of estrogen, the female reproductive hormone. Vaginal atrophy can be caused during perimenopause and can get aggravated in the postmenopausal phase. The global Postmenopausal Vaginal Atrophy Treatment market will reach xxx Mill......
  • Global Menopause Partnering 2010-2017
    Published: 01-Oct-2017        Price: US 1495 Onwards        Pages: 150
    "Delivery of this report will take 1-3 days after purchase." The Global Menopause Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. • Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understan......
  • Global Contraception Partnering 2010-2017
    Published: 01-Oct-2017        Price: US 1495 Onwards        Pages: 150
    "Delivery of this report will take 1-3 days after purchase." The Global Contraception Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. • Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides under......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs